Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

35.44
-0.8600-2.37%
Post-market: 35.440.00000.00%18:03 EDT
Volume:1.65M
Turnover:58.78M
Market Cap:1.12B
PE:20.49
High:36.58
Open:36.31
Low:35.27
Close:36.30
52wk High:50.79
52wk Low:23.23
Shares:31.61M
Float Shares:28.09M
Volume Ratio:2.64
T/O Rate:5.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.73
EPS(LYR):1.73
ROE:23.70%
ROA:7.27%
PB:3.71
PE(LYR):20.49

Loading ...

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

TIPRANKS
·
Jan 09

Collegium Pharmaceutical Is Maintained at Buy by Needham

Dow Jones
·
Jan 09

Collegium Pharmaceutical (COLL) Receives a Buy from Barclays

TIPRANKS
·
Jan 09

Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target

TIPRANKS
·
Jan 09

BRIEF-Collegium Pharmaceutical Outlook FY Revenue USD 805-825 Million

Reuters
·
Jan 08

Collegium Pharmaceutical Inc: on Track to Achieve Recently Increased Financial Guidance for 2025

THOMSON REUTERS
·
Jan 08

Press Release: Collegium Provides 2026 Financial Guidance and Business Update

Dow Jones
·
Jan 08

Truist Securities Adjusts Price Target on Collegium Pharmaceutical to $55 From $48, Maintains Buy Rating

MT Newswires Live
·
Jan 07

Press Release: Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Dow Jones
·
Dec 30, 2025

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Reuters
·
Dec 23, 2025

Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance

Simply Wall St.
·
Dec 16, 2025

EVP & Chief Commercial Officer Scott Dreyer Reports Disposal of Collegium Pharmaceutical Inc. Common Shares

Reuters
·
Dec 11, 2025

Collegium Pharmaceutical Director Rita J. Balice-Gordon Reports Sale of Common Shares

Reuters
·
Dec 10, 2025

Collegium Pharmaceutical Initiated at Overweight by Barclays

Dow Jones
·
Dec 09, 2025

Barclays Initiates Collegium Pharmaceutical at Overweight With $58 Price Target

MT Newswires Live
·
Dec 09, 2025

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025

A Fresh Look at Collegium Pharmaceutical (COLL) Valuation After Upbeat 2025 Guidance and Strong Q3 Earnings

Simply Wall St.
·
Nov 20, 2025

Collegium Pharmaceutical Q3 Revenue USD 209.4 Million Vs. IBES Estimate USD 191.2 Million

Reuters
·
Nov 20, 2025

Collegium Pharmaceutical price target raised to $48 from $45 at Truist

TIPRANKS
·
Nov 09, 2025

Collegium Pharmaceuticals Reports Record Growth and Optimistic Outlook

TIPRANKS
·
Nov 08, 2025